Lei Li

Lei Li

Auto-generated profile, based on publicly available information

Lei Li

Department of Interventional Medicine, The First Affiliated Hospital of Lanzhou University, Lanzhou, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2024 in JHEP Reports
Verified
Journal Article
Open access
DXDongdong Xia
Dongdong Xia
WBWei Bai
Wei Bai
QWQiuhe Wang
Qiuhe Wang
JCJin Wook Chung
Jin Wook Chung
XAXavier Adhoute
Xavier Adhoute
GHGuohong Han
Guohong Han
Current prognostic models for patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE) are not extensively validated and widely accepted. We aimed to develop and validate a continuous model incorporating tumor burden and biology for individual survival prediction and risk stratification. Overall, 4,377 treatment-naive candidates for whom TACE was recommended, from 39 centers in five countries, were enrolled and divided into training, internal validation, and two external validation datasets. The novel model was developed using a Cox multivariable regression analysis and compared with our original 6-and-12 model (the largest tumor size [ts, centimetres] + tumor number [tn]) and other available models in terms of predictive accuracy. The proposed model, named the ‘6-and-12 model 2.0’, was generated as ‘ts + tn + 1.5×log10 alpha-fetoprotein (AFP)’, showed good discrimination (C-index 0.674) and calibration (Hosmer–Lemeshow test p = 0.147), and outperformed current existing models. An easy-to-use stratification was proposed according to the different AFP levels (≤100, 100–400, 400–2,000, 2,000–10,000, 10,000–40,000, and >40,000 ng/ml) along with the corresponding tumor burden cutoffs (8/14, 7/13, 6/12, 5/11, 4/10, and any tumor burden); that is, if the AFP level was 400–2,000 ng/ml, the stratification should be low-(≤6)/intermediate-(6–12)/high-risk (>12) strata. Hence, it could divide the patients into three distinct risk categories with a median overall survival of 45.0 (95% CI, 40.1–49.9), 30.0 (95% CI, 26.1–33.9), and 15.4 (95% CI, 13.4–17.4) months (p <0.001) from low-risk to high-risk strata, respectively. These findings were confirmed in validation and subgroup analyses. The 6-and-12 model 2.0 significantly improved individual outcome predictions and better stratified the candidates recommended for TACE; thus, this model could be used in both clinical practice and trial design. In this international multicentre study, we developed and internally and externally validated a novel outcome prediction model for candidates with HCC who would be ideal for TACE. The model, called the 6-and-12 model 2.0, was based on 4,377 patients from 39 centers in five countries. The model offers individualized outcome prediction, outperforming the original 6-and-12 model score and other existing metrics across all datasets and subsets. Based on different levels of alpha-fetoprotein (AFP) and corresponding cut-offs of tumor burden, patients could be stratified into three risk strata with significantly different survival prognoses, which could provide a referential framework to control study heterogeneity and define the target population in future trial designs.

14 May 2020 in World Journal of Gastroenterology
Verified
Journal Article
Open access
YLYue Li
Yue Li
LLLei Li
Lei Li
HWHong-Lei Weng
Hong-Lei Weng
RLRoman Liebe
Roman Liebe
HDHuiguo Ding
Huiguo Ding
Computed tomography vs liver stiffness measurement and magnetic resonance imaging in evaluating esophageal varices in cirrhotic patients: A systematic review and meta-analysis


1 August 2020
Verified
Journal Article
Closed access
GXGao-Jie Xin
Gao-Jie Xin
JFJianhua Fu
Jianhua Fu
LLLei Li
Lei Li
XHXiao Han
Xiao Han
HMHong-Xu Meng
Hong-Xu Meng
JLJianxun Liu
Jianxun Liu

1 January 2022 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
BWBin Wu
Bin Wu
ZXZheng Xu
Zheng Xu
XLXing Li
Xing Li
CWChangyuan Wang
Changyuan Wang
LLLei Li
Lei Li
XMXiaodong Ma
Xiaodong Ma

22 September 2023
Verified
Conference Paper
Closed access
ZTZhiming Tang
Zhiming Tang
YLYu'E Lü
Yu'E Lü
BYBo Yang
Bo Yang
LLLei Li
Lei Li
JHJianghao Hao
Jianghao Hao
Diabetes is a common chronic Metabolic disorder, and its treatment has always been a hot research topic in the medical field. Traditional Chinese medicine has a significant therapeutic effect on it and has become one of the important ways for patients to choose treatment methods. In recent years, with the development and application of deep learning technology, more and more research has begun to attempt to use deep learning models to process traditional Chinese medicine case data, achieving automated information extraction and analysis. This study shows that BERT model and jieba segmentation algorithm have good effect in the study of the relationship between symptoms and Medication in diabetes medical record data, which is expected to provide scientific basis and reference for clinical treatment of traditional Chinese medicine.